Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
My Hep C Travel Diary, Hepatitis C Advocate
An in depth comparison of Mavyret versus Epclusa.
Some Tips For Taking Epclusa
Everyday I get emails from people around the world seeking information about generic hepatitis C medication...
Over the past five years Gilead has been averaging over $12 billion of profit per year from its sofosbuvir-based drugs.
Hepatitis C antibody tests can be confusing; Greg Jefferys explains hepatitis C screening tests in simple terms.
When doctors tell people with Hepatitis C not to get treated. A look at generic medications.
A look at how bribing bureaucrats and buying doctors brings about bad outcomes for public health.
Greg shows ways that people living with hepatitis C are defying obstacles and advocating for themselves and others.
Harsh words, strong emotions… these are the reasons I have delayed completing this post.
An in depth look at why sofosbuvir and daclatasvir may be the best hepatitis C treatment option.
Hepatitis C genotypes are like different races, or breeds, of the virus. Here is the long and the short of it...
Over the past couple of years, Fibroscan has become the test that almost everyone turns to in order to know their liver’s fibrosis level.
Greg’s adventures at EASL and in Europe
Greg’s experience at EASL 2018 in Paris
A journey across Europe to meet hepatitis C helpers.
What exactly is a generic medicine?
Greg meets interesting people during his visit to Mumbai
Still in India, Greg writes the next installment of his blog sitting in the back seat of a taxi driving from Udaipur to Jaipur.
Greg travels to India to take part in another documentary...
Two emails, two completely different stories.
A look at hepatitis C treatment in Latvia.
An explanation of the various hepatitis C treatment options for each genotype.
Do you have questions about hepatitis C transmission? If so, Greg has some answers.
In Ireland, the rate of Hepatitis C infection is one of the highest in the EU at about twice the international average.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.